₹2673.9
+3.04% today
· 30d +16.69%
as of 2026-11-09
Price · Daily Candles
“Glenmark surges with Q4 profit jump, but FIIs pare holdings amid high valuation.”
Glenmark Pharmaceuticals reported a robust Q4 2025 with revenue up 15.15% YoY to ₹3901 Cr and net profit increasing 15.86% YoY to ₹403 Cr. However, its TTM PE of 62.49 is significantly above the sector average, and the company is currently free-cash-flow negative at -2.38% of market cap.
BULL CASE
+Glenmark's net profit saw a strong 15.86% YoY increase in Q4 2025, reaching ₹403 Cr.
+Quarterly revenue grew 15.15% YoY to ₹3901 Cr in Q4 2025.
+The 1-year return stands at 64.25%, with the stock trading near its 52-week high of ₹2474.0, indicating strong recent momentum.
+Despite being free-cash-flow negative, ML predictions for 1-year sales growth are strong, with a recent 2-year rank of 0.814, rolling 4-year rank of 0.85, and stable 7-year rank of 0.868.
BEAR CASE
−The stock is trading at a TTM PE of 62.49, significantly higher than peers like Dr. Reddy's (19.55) and Cipla (29.52).
−Glenmark is currently free-cash-flow negative, with a FCF yield of -2.38% of its market cap.
−FIIs decreased their holding by 1.14% QoQ to 20.34% in Q4 2026, while DIIs also reduced their stake by 0.8% to 19.29%.
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹4157 Cr
-31.25% YoY
NET PROFIT
₹264 Cr
-56.78% YoY
OPM
20.39%
-20.59pp YoY
EPS
₹9.35
PE 62.49
Intrinsic value · DCF ₹1168.57 · Margin of safety -56.3% (overvalued) · FCF yield 2.78%
◇ Sector Position
Glenmark's TTM PE of 62.49 is notably higher than sector leaders like Sun Pharma (40.41 PE, 22.46% ROCE) and Dr. Reddy's (19.55 PE, 27.63% ROCE), positioning it as a pricier option despite a ROCE of 19.0%.
PEERPEROCE %
GLENMARK62.4919.0
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒
70
SCORE / 100
Overall
6-axis composite of the sections below.
Performance
STRONG
90
Valuation
STRETCHED
20
Growth
STRONG
88
Profitability
HIGH
78
Technicals
NEUTRAL
65
Risk
LOW
80
Key Stats
TTM PE
62.49
P/B
6.92
52W HIGH
₹2714.0
OFF HIGH
-1.48%
DIV YIELD
0.21%
MKT CAP
₹75215 Cr
◉ Active Signals
MACDBullish46.9611
RSI(14)Bearish76.16
Near 52W HighBullish-1.48
Street Consensus
11 analysts₹2227.36
mean target
Low ₹1500.0Now ₹2673.9High ₹2735.0
⧉ Strategy Fit 🔒